Skip to content

The Use of Topical Anaesthetic in the Banding of Internal Haemorrhoids

The Use of Topical Anaesthetic in the Banding (TAB) of Internal Haemorrhoids: A Feasibility Study.

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04031131
Acronym
TAB
Enrollment
38
Registered
2019-07-24
Start date
2019-10-17
Completion date
2020-03-01
Last updated
2020-10-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemorrhoids

Keywords

Haemorrhoid, Banding, Topical Anaesthetic

Brief summary

The investigators' aim is to assess if they can complete a study measuring the effect of local anaesthetic gel (Instillagel) on reducing pain experienced by patients undergoing a common treatment for haemorrhoids (piles). This treatment is called rubber band ligation and is commonly performed in the investigators'clinics.

Detailed description

A feasibility trial assessing patient recruitment, retention, randomization, and surgeon acceptability of topical anaesthetic use during rubber band ligation of haemorrhoids. A patient and assessor blinded feasibility trial. The trial population will prospectively be recruited from colorectal surgery outpatients. Patients will be randomized to two groups to receive: lubricating gel (K-Y Jelly) and topical anaesthetic gel (Instillagel) or lubricating gel alone (the standard care). The intervention group will receive lubricating gel and topical anaesthetic gel (containing lidocaine active ingredient) administered rectally, whilst the control group will receive lubricating gel alone (standard care). This will be carried out in Colorectal Outpatients. The band ligation of the haemorrhoids should occur between 5-10 minutes after administration of the topical anaesthetic/lubricating gel. Pain scores and the use of oral analgesia will be measured immediately after the procedure (5 minutes), upon leaving the clinic (approximately 30 minutes after), at 4 hours, and 72 hours following the procedure. Vasovagal symptoms or other complications will be recorded whilst the patient is in the clinic. At 1 month post procedure, patients will be phoned to determine if any adverse events have occurred.

Interventions

Topical Anaesthetic Gel (Instillagel) licensed for rectal administration.

OTHERKY Gel

Lubricant Gel

Sponsors

Julie Dawson
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

Blinded to assessors and patients

Intervention model description

The trial will be a randomised control trial blinded to patient and assessor (the clinician collecting data at 4 hours, 72 hours and 1 month after the procedure. Randomisation will be achieved by a computer software. Administrators will be aware of which group the patient being treated is in. Half of the patients (n=30) will receive the intervention treatment (Instillagel topical anaesthetic) and lubricating gel (standard of care), the other half will receive the standard of care alone (lubricating gel) (n=30) before the procedure. The standard of care is to use no form of analgesia, with K-Y gel only being used as a lubricant. Researchers will be asked to apply the allocated treatment 5-10 minutes before the procedure. The primary end points will be: patient recruitment rate, patient acceptability, surgeon acceptability, patient retention. The secondary endpoints will be: pain scores using the 10-point visual analogue scale.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Symptomatic grade 1-3 haemorrhoid disease, 18+ years old, English is the first language.

Exclusion criteria

* Allergy to active ingredients of Instillagel, Allergy to local anaesthetic, Chronic liver disease, Grade 4 haemorrhoid disease, Pregnancy, Inflammatory bowel disease, Pre-existing anorectal disease.

Design outcomes

Primary

MeasureTime frameDescription
Patient recruitment rate5 monthsPatient recruitment rate via screening log.
Treatment acceptability to patients5 monthsTreatment acceptability to patients via study questionnaire. A visual analogue scale to be used, 0 - 10 with '0' being no pain and '10' being worst pain possible.
Patient retention5 monthsPatient retention via recruitment log.

Secondary

MeasureTime frameDescription
Assess if the intervention reduced pain associated with haemorrhoids up to 72 hours after the procedure,72 hoursAssess if the intervention reduced pain associated with haemorrhoids up to 72 hours after the procedure via study questionnaire.
Assess hospital readmission 1 month after the procedure.1 monthAssess hospital readmission 1 month after the procedure via review of hospital notes. The number of patients requiring additional analgesia will be compared between the two groups.
Assess if the intervention reduces vasovagal symptoms up to 72 hours after the procedure72 hoursAssess if the intervention reduces vasovagal symptoms up to 72 hours after the procedure via study questionnaire.
Assess if the intervention reduced oral analgesia burden following the procedure72 hoursAssess if the intervention reduced oral analgesia burden following the procedure via study questionnaire.

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026